From Cellulite to smooth skin: Is Viagra the new dream cream?

Medical Hypotheses

Volumn 73, Issue 1, 2009, Pages 118-119

  Altabas, Karmela ^a   Altabas, Velimir ^a   Berković, Maja Cigrovski ^a   Rotkvić, Vanja Zjačić ^a  

^a SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHODIESTERASE III; SILDENAFIL;

DRUG EFFECT; DRUG INHIBITION; ERECTILE DYSFUNCTION; HUMAN; LETTER; LIPOLYSIS; MICROCIRCULATION; PRIORITY JOURNAL; SKIN;

3',5'-CYCLIC-GMP PHOSPHODIESTERASES; ADIPOSE TISSUE; COSMETICS; HUMANS; MODELS, BIOLOGICAL; PIPERAZINES; PURINES; SKIN AGING; SULFONES;

EID: 64849092285     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2009.01.020     Document Type: Letter

References (14)

1. Rossi A.B., and Vergnanini A.L. Cellulite: a review. JEADV 14 (2000) 251-262
2. Avram M.M. Cellulite: a review of its physiology and treatment. J Cosmet Las Ther 6 (2004) 181-185
3. Smalls L.K., Hicks M., Passaretti D., Gersin K., Kitzmiller W.J., Bakhsh A., et al. Effect of weight loss on cellulite: gynoid lypodystrophy. Plast Reconstr Surg 118 (2006) 510-516
4. Rawlings: cellulite and its treatment. Int J Cosmet Sci 2006;28:175-90.
5. Jeon Y.H., Heo Y.S., Kim C.M., Hyun T.G., Lee S., Ro S., et al. Phosphodiesteraze: overview of protein structures, potential therapeutic applications and recent progress in drug development. CMLS Cell Mol Life Sci 62 (2006) 1198-1220
6. Carmen G.Y., and Víctor S.M. Signalling mechanisms regulating lipolysis. Cell Signal (2006) 401-408
7. Lafontan M., Cedric M., Berlan M., Crampes F., Sengens C., Galitzky J., et al. Control of lipolysis by natriuretic peptides and cyclic GMP. Trends Endocrinol Metab 19 (2008) 130-137
8. Cheung P., Yang G., and Boden G. Milrinone, a selective phosphodiesterase 3 inhibitor, stimulates lipolysis, endogenous glucose production, and insulin secretion. Metabolism 52 (2003) 1496-1500
9. Park J.W., Mrovietz C., Chung N., and Jung F. Sildenafil improves cutaneous microcirculation in patients with coronary artery disease: a monocentric, prospective, double-blind, placebo-controlled randomized cross-over study. Clin Hemorheol Microcirc 31 (2004) 173-183
10. Gertner E. Treatment with sildenafil for the healing of refractory skin ulcerations in the antiphospholipid syndrome. Lupus 12 (2003) 133-135
11. Dell'Agli M, Galli GV, Bosisio E. Inhibition of cGMP-phosphodiesterase-5 by biflavones of Ginkgo biloba. Planta Med 2006;72:468-70.
12. Shields K.M., and Hrometz S.L. Use of sildenafil for female sexual dysfunction. Ann Pharmacother 40 (2006) 931-934
13. Lia J., and Cjang T.W. Determination of transdermal sildenafil in nude mouse skin by reversed-phase high performance liquid chromatography. J Chromatogr B Biomed Sci Appl 765 (2001) 161-165
14. Calhourn D.A., Murthy S.N., Bryant B.G., Luedtke S./A., and Bhatt-Mehta V. Recent advances in neonatal pharmacotherapy. Ann Pharmacother 40 (2006) 710-719